Category: Dispatches

Cannabis Clinicians Break Into “The Literature”

The journal Epilepsy & Behavior has just published a special issue entitled “Cannabinoids and Epilepsy” that includes a paper by Drs. Dustin Sulak, Russell Saneto, and Bonni Goldstein, “The current status of artisanal cannabis for the treatment of epilepsy in the United States.”  Here’s the abstract: The widespread patient use of artisanal cannabis preparations has preceded quality validation of cannabis use for epilepsy. Neurologists and cannabinoid specialists are increasingly in a position to monitor and guide the use of herbal cannabis in epilepsy patients. We report the retrospective data on efficacy and adverse effects of artisanal cannabis in Patients...

Read More

Publicizing the NAS Report

“Oh, that this 2/2 too sullied flesh would melt…” —Hamlet A report called The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, released in January by the National Academies of Sciences, Engineering, and Medicine (NAS), was the subject of a “Stakeholders Engagement Meeting” streamed from the NAS building in Washington, DC yesterday.  It can be viewed here INFO TK in its entirety. Meanwhile, here are some screenshots and editorial comments.  The authors of the report were evaluating what they called the “strength of the ‘evidence'” regarding the health benefits and risks of cannabis as medicine. By far the strongest evidence, from their perspective, are randomized, placebo-controlled clinical trials (RCTs). Clinical evidence —the findings and observations of physicians who monitor cannabis use by patients— is ignored completely. It’s not even “low quality!” Retro Messages: 1. The number-one finding makes cannabis use at a young age seem causal when in fact it is a response to an environment (family, neighborhood, school) from which the young user seeks relief.   2.Women who experience nausea during pregnancy tend to smoke more and eat less. And it may be that the Endocannabinoid System, in its wisdom, is making for a slightly easier delivery. The pot-users’ babies gain weight fast and in about a month have caught up with the abstainers’ babies. 3. Cannabis smoking doesn’t exacerbate COPD, according to the great UCLA pulmonologist Donald...

Read More

Improving Microbial Detection Standards for Cannabis

By Kevin McKernan February 8, followed by an editorial retro message. On February 7, the Daily Mail reported a cancer patient in northern California died from a fungal infection that authorities suspect was caused by the inhalation of contaminated medical cannabis. This tragic result, unfortunately, comes as no surprise to our team at Medicinal Genomics.  Since 2015, Medicinal Genomics has been studying the spectrum of microbes that can be found on medicinal Cannabis.  As a result of this research, our company has published two papers warning the community that the widely-used method for detecting microbial contamination on cannabis, petri dish...

Read More

Notes on the MBC Marijuana Task Force Meeting

Ellen Komp of California NORML drove out to Sacramento with me (FG) and Stephen Robinson, MD, of the Society  Cannabis Clinicians for the February 8 meeting of the Medical Board of California’s Marijuana Task Force.  This is her quick rundown: The meeting was convened by Marijuana Task Force members Dr. Howard Krauss (opthalmologist) and Kristina Lawson, public member (land use attorney and former mayor of Walnut Creek), along with Kimberly Kirchmeyer, med board executive director and Kerrie Webb, Staff Counsel. Notably absent was anyone from the Center for Medical Cannabis Research, despite the requirement in SB 643 that the...

Read More

Note to the MBC Marijuana Task Force 2/8/17

Here are some additional articles published by cannabis clinicians in O’Shaughnessy’s showing the strength of aggregated case reports. We hope the MBC Marijuana Task Force will give them serious consideration. Marijuana in California, 1996-2006 by Mikuriya et al Cannabis Eases Post Traumatic Stress by Tod Mikuriya, MD Cannabis as a First-line Treatment for Childhood Mental Disorders by Tod Mikuriya MD Cannabis Alleviates Symptoms of Crohn’s Disease by Jeffrey Hergenrather, MD About My Practice by Jeffrey Hergenrather, MD SCC Study of Crohn’s Patients: A Template for clinical research? by Jeffrey Hergenrather, MD  (after  Abrams and Sidney) On the subject of...

Read More